Intra-Cranial Pressure (ICP) Monitoring Devices - Medical Devices Pipeline Assessment, 2019

Table of Contents

• 1.1 List of Tables 4
• 1.2 List of Figures 6

2 Introduction 7

• 2.1 Intra-Cranial Pressure (ICP) Monitoring Devices Overview 7

3 Products under Development 8

• 3.1 Intra-Cranial Pressure (ICP) Monitoring Devices - Pipeline Products by Stage of Development 8
• 3.2 Intra-Cranial Pressure (ICP) Monitoring Devices - Pipeline Products by Territory 9
• 3.3 Intra-Cranial Pressure (ICP) Monitoring Devices - Pipeline Products by Regulatory Path 10
• 3.4 Intra-Cranial Pressure (ICP) Monitoring Devices - Pipeline Products by Estimated Approval Date 11
• 3.5 Intra-Cranial Pressure (ICP) Monitoring Devices - Ongoing Clinical Trials 12

4 Intra-Cranial Pressure (ICP) Monitoring Devices - Pipeline Products under Development by Companies 13

• 4.1 Intra-Cranial Pressure (ICP) Monitoring Devices Companies - Pipeline Products by Stage of Development 13
• 4.2 Intra-Cranial Pressure (ICP) Monitoring Devices - Pipeline Products by Stage of Development 15

5 Intra-Cranial Pressure (ICP) Monitoring Devices Companies and Product Overview 16

• 5.1 Ad-Tech Medical Instrument Corp Company Overview 16
  • 5.1.1 Ad-Tech Medical Instrument Corp Pipeline Products & Ongoing Clinical Trials Overview 16
• 5.2 Boston Neurosciences Company Overview 17
  • 5.2.1 Boston Neurosciences Pipeline Products & Ongoing Clinical Trials Overview 17
• 5.3 City, University of London Company Overview 21
  • 5.3.1 City, University of London Pipeline Products & Ongoing Clinical Trials Overview 21
• 5.4 Columbia University Company Overview 22
  • 5.4.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview 22
• 5.5 Drexel University Company Overview 23
  • 5.5.1 Drexel University Pipeline Products & Ongoing Clinical Trials Overview 23
• 5.6 Duke University Company Overview 24
  • 5.6.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview 24
• 5.7 HeadSense Medical Ltd. Company Overview 25
  • 5.7.1 HeadSense Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 25
• 5.8 Integra LifeSciences Holdings Corp Company Overview 29
  • 5.8.1 Integra LifeSciences Holdings Corp Pipeline Products & Ongoing Clinical Trials Overview 29
• 5.9 Integrated Sensing Systems Inc Company Overview 30
  • 5.9.1 Integrated Sensing Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 30
• 5.10 Irras AB Company Overview 32
  • 5.10.1 Irras AB Pipeline Products & Ongoing Clinical Trials Overview 32
• 5.11 Koronis Biomedical Technologies Corporation Company Overview 35
  • 5.11.1 Koronis Biomedical Technologies Corporation Pipeline Products & Ongoing Clinical Trials Overview 35
• 5.12 Neural Analytics, Inc. Company Overview 36
  • 5.12.1 Neural Analytics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 36
• 5.13 Neurallys Company Overview 37
  • 5.13.1 Neurallys Pipeline Products & Ongoing Clinical Trials Overview 37
• 5.14 NeuroDx Development, LLC Company Overview 38
  • 5.14.1 NeuroDx Development, LLC Pipeline Products & Ongoing Clinical Trials Overview 38
• 5.15 Nisonic AS Company Overview 39
  • 5.15.1 Nisonic AS Pipeline Products & Ongoing Clinical Trials Overview 39
• 5.16 Northwestern University Company Overview 40
  • 5.16.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 40
• 5.17 Orsan Medical Technologies Ltd. Company Overview 41
  • 5.17.1 Orsan Medical Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview 41
• 5.18 Qura Inc Company Overview 42
  • 5.18.1 Qura Inc Pipeline Products & Ongoing Clinical Trials Overview 42
• 5.19 Remote Vital Monitoring Inc Company Overview 43
  • 5.19.1 Remote Vital Monitoring Inc Pipeline Products & Ongoing Clinical Trials Overview 43
• 5.20 Stanford University Company Overview 44
  • 5.20.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview 44
• 5.21 The Feinstein Institute for Medical Research Company Overview 45
  • 5.21.1 The Feinstein Institute for Medical Research Pipeline Products & Ongoing Clinical Trials Overview 45
• 5.22 Third Eye Diagnostics, Inc. Company Overview 46
  • 5.22.1 Third Eye Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 46
• 5.23 University of Illinois Company Overview 47
  • 5.23.1 University of Illinois Pipeline Products & Ongoing Clinical Trials Overview 47
• 5.24 Virginia Commonwealth University Company Overview 48
  • 5.24.1 Virginia Commonwealth University Pipeline Products & Ongoing Clinical Trials Overview 48
• 5.25 Vivonics Inc Company Overview 49
  • 5.25.1 Vivonics Inc Pipeline Products & Ongoing Clinical Trials Overview 49
• 5.26 Washington University in St Louis Company Overview 50
  • 5.26.1 Washington University in St Louis Pipeline Products & Ongoing Clinical Trials Overview 50
• 5.27 Wisconsin Institute of Nuclear Systems Company Overview 51
  • 5.27.1 Wisconsin Institute of Nuclear Systems Pipeline Products & Ongoing Clinical Trials Overview 51

6 Intra-Cranial Pressure (ICP) Monitoring Devices - Recent Developments 52

• 6.1 Nov 21, 2019: IRRAS announces FDA clearance of new 510(K) filing to expand the time of use of IRRAflow 52
• 6.2 Nov 18, 2019: Nisonic Demonstrates Automatic Measurements of Optic Nerve Sheath Diameter as a Marker for Increased Intracranial Pressure Using Transorbital Ultrasound at Medica In Düsseldorf, Germany 52
• 6.3 Nov 07, 2019: Penumbra reports third quarter 2019 financial results 53
• 6.4 Oct 24, 2019: Integra LifeSciences reports third quarter 2019 financial results 53
• 6.5 Oct 18, 2019: IRRAS announces participation at the 69th Congress of Neurological Surgeons’ Annual Meeting (CNS 2019) 54

7 Appendix 69

• 7.1 Methodology 69
• 7.2 About GlobalData 72
• 7.3 Contact Us 72